The proposed mechanism in NSCLC explains that miR-197 has a direct inhibitory effect on the cyclin-dependent kinase CKS1B, which promotes PD-L1 expression by activating STAT3 [12]. Here, STAT3 is linked to non-small cell lung carcinoma.